URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Neil Blumberg

Concepts (549)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Blood Transfusion
74
1978
171
14.310
Why?
Platelet Transfusion
28
1987
85
10.250
Why?
ABO Blood-Group System
29
1978
66
7.870
Why?
Blood Platelets
31
1981
277
5.490
Why?
Erythrocyte Transfusion
14
1982
57
3.900
Why?
Blood Group Incompatibility
15
1983
37
3.340
Why?
Blood Grouping and Crossmatching
17
1984
32
3.120
Why?
Isoantibodies
22
1982
57
2.720
Why?
Blood Component Transfusion
7
1992
21
2.430
Why?
Blood Transfusion, Autologous
12
1982
24
2.230
Why?
Inflammation
9
2003
534
2.160
Why?
Postoperative Complications
13
1990
733
2.110
Why?
Leukemia
8
1982
158
1.960
Why?
Humans
158
1974
36274
1.960
Why?
Cardiac Surgical Procedures
4
2002
80
1.950
Why?
Hemorrhage
5
1983
180
1.870
Why?
HLA Antigens
7
1982
99
1.760
Why?
Fever
5
2001
111
1.730
Why?
Leukocyte Reduction Procedures
6
2004
11
1.710
Why?
CD40 Ligand
8
2001
91
1.710
Why?
Leukocytes
9
1992
189
1.690
Why?
Blood Preservation
6
1981
24
1.680
Why?
Acute Lung Injury
3
2010
24
1.660
Why?
Thrombosis
4
2008
200
1.510
Why?
Neoplasm Recurrence, Local
14
1985
288
1.460
Why?
Immunity
5
1989
66
1.440
Why?
Blood Donors
6
1982
27
1.360
Why?
Leukapheresis
4
1978
14
1.310
Why?
Coronary Artery Bypass
8
1983
106
1.310
Why?
Thrombocytopenia
5
1988
74
1.270
Why?
Blood Component Removal
2
2003
11
1.240
Why?
Infection
10
1989
66
1.220
Why?
Erythrocytes
6
1983
337
1.180
Why?
Immune Tolerance
7
1990
144
1.160
Why?
Antibodies
4
1983
212
1.140
Why?
Hematologic Neoplasms
3
2006
35
1.120
Why?
Female
61
1978
19838
1.050
Why?
Male
53
1978
19675
0.980
Why?
Fibrinogen
4
1988
149
0.970
Why?
Factor VIII
3
1988
50
0.970
Why?
Neoplasms
13
1974
739
0.950
Why?
Blood Banks
3
2001
12
0.930
Why?
Histocompatibility Testing
2
2005
37
0.930
Why?
Lewis Blood-Group System
7
1983
11
0.910
Why?
Anemia
3
1998
78
0.910
Why?
Cross Infection
4
1992
88
0.890
Why?
Length of Stay
3
2002
287
0.890
Why?
Communicable Diseases
2
1997
23
0.880
Why?
Retrospective Studies
18
1982
2267
0.880
Why?
Bone Marrow Transplantation
4
1994
197
0.850
Why?
Vascular Diseases
2
2006
70
0.850
Why?
Blood Specimen Collection
2
1981
28
0.850
Why?
Megakaryocytes
7
2004
67
0.840
Why?
Hospital Mortality
2
2008
137
0.830
Why?
Middle Aged
32
1978
9837
0.830
Why?
Randomized Controlled Trials as Topic
5
1998
411
0.820
Why?
Cardiopulmonary Bypass
1
2012
47
0.800
Why?
Immunoglobulin G
12
1983
488
0.790
Why?
Bacterial Infections
7
1982
130
0.790
Why?
Erythropoietin
2
1998
28
0.780
Why?
Hematopoietic Stem Cell Transplantation
4
2003
131
0.770
Why?
Aged
28
1978
7269
0.770
Why?
Hemostasis
2
2010
62
0.760
Why?
Postoperative Hemorrhage
1
2011
19
0.760
Why?
Meta-Analysis as Topic
2
1998
36
0.750
Why?
Leukocyte Transfusion
1
2010
5
0.710
Why?
Blood Group Antigens
7
1978
36
0.690
Why?
Interleukins
1
2010
63
0.690
Why?
Rh Isoimmunization
2
1987
14
0.680
Why?
Colorectal Neoplasms
4
1990
137
0.680
Why?
Adult
34
1978
11351
0.680
Why?
Peroxisome Proliferator-Activated Receptors
1
2009
4
0.680
Why?
Clofibric Acid
1
2009
6
0.680
Why?
Plateletpheresis
5
1981
9
0.670
Why?
Th2 Cells
5
1996
94
0.670
Why?
Hypolipidemic Agents
1
2009
26
0.660
Why?
Plasma
5
1982
33
0.650
Why?
Heart-Assist Devices
1
2009
34
0.640
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
48
0.630
Why?
Graft Survival
3
1988
148
0.620
Why?
Pregnancy
12
1978
1966
0.610
Why?
Transplantation, Homologous
10
1991
276
0.610
Why?
Health Plan Implementation
2
2002
20
0.600
Why?
Incidence
7
1990
685
0.600
Why?
Communicable Disease Control
1
2007
27
0.590
Why?
Heart Valve Prosthesis Implantation
2
2002
9
0.580
Why?
Platelet Activation
5
2006
52
0.580
Why?
Sepsis
4
1979
110
0.570
Why?
Antigen-Antibody Complex
3
1989
55
0.530
Why?
Blood Loss, Surgical
3
2004
44
0.520
Why?
Th1 Cells
3
1996
70
0.510
Why?
Cohort Studies
9
1996
969
0.500
Why?
Catheters, Indwelling
1
2005
70
0.500
Why?
Rh-Hr Blood-Group System
6
1978
47
0.480
Why?
Immunoglobulin M
4
1983
141
0.470
Why?
Hip Prosthesis
2
1991
40
0.450
Why?
Treatment Outcome
9
1990
2615
0.450
Why?
Interleukin-10
3
1998
104
0.440
Why?
Cytokines
4
1995
565
0.440
Why?
Bone Marrow
2
2003
287
0.430
Why?
Head and Neck Neoplasms
1
2004
83
0.430
Why?
Antineoplastic Agents
4
1974
619
0.420
Why?
PPAR gamma
4
2006
99
0.420
Why?
Cost-Benefit Analysis
6
1983
215
0.410
Why?
NF-kappa B
3
2009
432
0.410
Why?
Infant, Newborn
7
1983
1844
0.410
Why?
Heart Diseases
1
2002
142
0.390
Why?
Prospective Studies
6
1990
1689
0.390
Why?
Child
9
1983
4155
0.380
Why?
Risk Factors
12
1988
2345
0.380
Why?
Dinoprostone
2
2001
207
0.380
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2001
82
0.370
Why?
P Blood-Group System
2
1987
2
0.360
Why?
Infant
6
1980
2278
0.360
Why?
Enzyme-Linked Immunosorbent Assay
10
1983
462
0.350
Why?
Interleukin-6
3
2007
339
0.340
Why?
Time Factors
13
1974
3182
0.340
Why?
Antigens
2
1987
99
0.340
Why?
Immune System
2
1992
71
0.340
Why?
Prostaglandin D2
3
2004
63
0.330
Why?
Kidd Blood-Group System
2
1983
2
0.330
Why?
Thrombopoiesis
2
2008
15
0.330
Why?
Autoimmune Diseases
2
1988
80
0.330
Why?
Uterine Cervical Neoplasms
3
1986
125
0.330
Why?
Virus Diseases
3
1990
83
0.330
Why?
Costs and Cost Analysis
4
1995
90
0.320
Why?
Arthroplasty, Replacement, Knee
1
1998
21
0.320
Why?
Adolescent
8
1983
4766
0.310
Why?
Acquired Immunodeficiency Syndrome
4
1983
193
0.310
Why?
Arthroplasty, Replacement, Hip
1
1998
45
0.310
Why?
Colonic Neoplasms
3
1985
124
0.300
Why?
Child, Preschool
4
2001
2660
0.300
Why?
Platelet Aggregation
5
1983
66
0.290
Why?
Acute Disease
5
1982
586
0.290
Why?
Kidney Transplantation
3
1984
175
0.280
Why?
Lymphoma
2
1994
162
0.280
Why?
Urinary Tract Infections
3
1991
64
0.280
Why?
Women's Health
2
2006
60
0.280
Why?
Receptors, Complement
1
1996
18
0.270
Why?
Receptors, Fc
1
1996
70
0.260
Why?
Antibody Specificity
4
1983
106
0.260
Why?
Bone Marrow Purging
1
1995
4
0.250
Why?
Platelet Count
5
1981
50
0.250
Why?
Cell Separation
5
1981
231
0.240
Why?
Fetal Blood
4
1985
91
0.230
Why?
Host vs Graft Reaction
1
1993
2
0.230
Why?
Prostatic Neoplasms
3
1986
555
0.230
Why?
C-Reactive Protein
2
2010
122
0.230
Why?
Hematologic Diseases
1
1993
39
0.230
Why?
Granulocytes
4
1978
80
0.220
Why?
Pathology
1
1993
33
0.220
Why?
Models, Biological
4
1974
1008
0.220
Why?
Antigens, Human Platelet
2
1994
8
0.210
Why?
Aged, 80 and over
7
1987
2529
0.210
Why?
Aspirin
2
2007
59
0.210
Why?
Platelet Aggregation Inhibitors
2
2006
61
0.210
Why?
Biological Markers
2
2010
560
0.200
Why?
Postoperative Care
1
2012
126
0.200
Why?
Pulmonary Embolism
1
2012
57
0.200
Why?
Spinal Fusion
1
1992
53
0.200
Why?
Leukemia, Myeloid
1
1992
119
0.200
Why?
Publication Bias
1
2011
8
0.200
Why?
Blood Proteins
1
1992
95
0.200
Why?
Neoplasm Staging
2
1988
338
0.200
Why?
Organizational Policy
1
2011
33
0.200
Why?
Animals
12
1982
16093
0.190
Why?
Fetomaternal Transfusion
2
1987
8
0.190
Why?
Venous Thrombosis
1
2012
80
0.190
Why?
Tanacetum parthenium
1
2011
3
0.190
Why?
Outcome and Process Assessment (Health Care)
1
2011
85
0.190
Why?
Pulmonary Circulation
1
2010
46
0.190
Why?
Survival Analysis
3
1994
606
0.190
Why?
Risk
2
2000
368
0.190
Why?
Feasibility Studies
1
2011
202
0.190
Why?
Sesquiterpenes
1
2011
24
0.190
Why?
Graft vs Host Disease
4
1994
90
0.190
Why?
Guideline Adherence
1
2011
83
0.190
Why?
Publishing
1
2011
45
0.190
Why?
Ligands
3
2006
288
0.180
Why?
Program Evaluation
1
2011
206
0.180
Why?
Uremia
1
1990
27
0.180
Why?
Rectal Neoplasms
2
1986
82
0.180
Why?
Calcitonin
1
2010
42
0.170
Why?
Fibrinolytic Agents
1
2010
61
0.170
Why?
Interleukin-12
1
2010
43
0.170
Why?
Drug Resistance
1
2010
102
0.170
Why?
Heart Defects, Congenital
1
2010
103
0.170
Why?
Protein Precursors
1
2010
84
0.170
Why?
Neutralization Tests
2
1983
129
0.170
Why?
United States
6
1996
2688
0.170
Why?
Thromboxane B2
2
2004
12
0.170
Why?
Odds Ratio
2
2007
315
0.170
Why?
Heparin
1
2010
122
0.160
Why?
Prognosis
4
1988
1083
0.160
Why?
Intensive Care Units
1
2010
111
0.160
Why?
Hospitalization
1
2012
399
0.160
Why?
Forkhead Transcription Factors
1
2009
52
0.160
Why?
Proteome
1
2009
50
0.160
Why?
Hematocrit
3
1981
112
0.160
Why?
Heart Transplantation
1
2009
71
0.160
Why?
Immunization
2
1983
175
0.160
Why?
Anticoagulants
1
2010
135
0.160
Why?
Proteomics
1
2009
73
0.160
Why?
Antibodies, Monoclonal
3
1984
711
0.160
Why?
Heme Oxygenase-1
1
2008
51
0.160
Why?
Erythrocyte Count
1
1988
28
0.150
Why?
Transport Vesicles
1
2008
7
0.150
Why?
Immunity, Innate
1
1989
98
0.150
Why?
Retinoid X Receptors
1
2008
25
0.150
Why?
Databases, Factual
1
2009
156
0.150
Why?
Culture Media, Conditioned
1
2007
62
0.150
Why?
Jurisprudence
1
1987
11
0.150
Why?
Confidentiality
1
1987
16
0.150
Why?
Research
1
2008
178
0.150
Why?
Surgical Wound Infection
1
2007
57
0.150
Why?
Erythroblastosis, Fetal
2
1983
35
0.140
Why?
Intraoperative Care
2
1988
29
0.140
Why?
Gene Expression Regulation, Enzymologic
1
2008
193
0.140
Why?
Vaccines, Synthetic
1
1987
90
0.140
Why?
Leukopenia
1
2006
24
0.140
Why?
Patient Care
1
1987
40
0.140
Why?
Immunosorbent Techniques
4
1983
27
0.140
Why?
Plasma Exchange
2
1983
18
0.140
Why?
Graft Rejection
2
1984
143
0.140
Why?
Eicosanoids
1
2006
16
0.140
Why?
Diabetes Mellitus, Type 2
1
2009
224
0.140
Why?
Antigens, CD40
1
2006
54
0.130
Why?
Lung Injury
1
2006
79
0.130
Why?
Proportional Hazards Models
1
2007
450
0.130
Why?
Hemagglutination Tests
4
1983
24
0.130
Why?
Family Practice
1
1987
181
0.130
Why?
New York
2
2005
1305
0.130
Why?
Thalassemia
1
2005
23
0.120
Why?
Recurrence
3
1989
691
0.120
Why?
Vidarabine
1
2005
26
0.120
Why?
Diabetes Mellitus
1
2006
169
0.120
Why?
Anemia, Sickle Cell
1
2005
47
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
2
1992
429
0.120
Why?
Cytomegalovirus Infections
1
2004
76
0.120
Why?
Erythrocyte Aging
2
1982
6
0.120
Why?
Hemagglutinins
1
1984
24
0.120
Why?
Neutrophils
1
2006
312
0.120
Why?
Agglutinins
1
1983
4
0.110
Why?
Infant, Premature
1
2005
232
0.110
Why?
Antigens, Thy-1
1
2003
60
0.110
Why?
Chloroquine
3
1984
18
0.110
Why?
Blood
3
1982
93
0.110
Why?
Disease-Free Survival
1
2004
198
0.110
Why?
Blood Coagulation Tests
1
1983
36
0.110
Why?
Technetium
1
1983
50
0.110
Why?
Tissue Donors
1
2003
69
0.110
Why?
Muscle, Smooth
1
2003
99
0.110
Why?
Age Factors
4
1982
1128
0.110
Why?
Heart Valves
1
2002
8
0.110
Why?
Iron
1
2004
147
0.110
Why?
Sample Size
1
2002
33
0.110
Why?
Receptors, Cytoplasmic and Nuclear
1
2004
137
0.110
Why?
Down-Regulation
2
1990
237
0.100
Why?
Erythrocyte Membrane
1
1983
81
0.100
Why?
Hemodilution
1
2002
8
0.100
Why?
Sex Characteristics
1
2003
138
0.100
Why?
Immunoenzyme Techniques
1
1983
220
0.100
Why?
Cardiovascular Diseases
1
2006
277
0.100
Why?
Health
1
1982
14
0.100
Why?
Probability
3
1983
302
0.100
Why?
Safety
1
2002
101
0.100
Why?
Antihypertensive Agents
1
1982
79
0.100
Why?
Adjuvants, Immunologic
1
2002
117
0.100
Why?
Chromatography, Gel
2
1989
109
0.100
Why?
Leukemia, Myeloid, Acute
1
2003
177
0.100
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2001
12
0.100
Why?
Purpura
1
2001
16
0.100
Why?
Adrenal Cortex Hormones
1
1982
96
0.100
Why?
Aging
1
2007
707
0.100
Why?
Heart Valve Prosthesis
1
2001
40
0.100
Why?
Plasmapheresis
1
1981
26
0.100
Why?
Survival Rate
1
2003
618
0.090
Why?
Antigen-Antibody Reactions
2
1989
37
0.090
Why?
Twins, Conjoined
1
1980
3
0.090
Why?
Duodenal Obstruction
1
1980
9
0.090
Why?
Patient Advocacy
1
2000
49
0.090
Why?
Patient Selection
1
2002
212
0.090
Why?
Research Design
1
2002
336
0.090
Why?
Cells, Cultured
4
2003
2479
0.090
Why?
Hemoglobinopathies
3
1983
6
0.090
Why?
Clinical Trials as Topic
2
1998
671
0.090
Why?
Multiple Organ Failure
1
1999
38
0.090
Why?
Cyclooxygenase 2
1
2001
226
0.090
Why?
Prostaglandin-Endoperoxide Synthases
1
2001
169
0.090
Why?
Cell Line
3
2004
1585
0.080
Why?
Fetus
1
1980
253
0.080
Why?
Mass Screening
1
1982
247
0.080
Why?
Health Status
1
1982
283
0.080
Why?
Hemoglobin A
1
1998
2
0.080
Why?
Autoantibodies
2
1988
98
0.080
Why?
Serum Amyloid A Protein
1
1998
23
0.080
Why?
Receptors, Interleukin-2
1
1998
30
0.080
Why?
Decision Making
1
2000
223
0.080
Why?
Lymphocyte Count
1
1998
53
0.080
Why?
Causality
1
1998
45
0.080
Why?
Quality-Adjusted Life Years
1
1998
53
0.080
Why?
Emergencies
1
1978
81
0.080
Why?
Isoenzymes
1
2001
439
0.080
Why?
History, 20th Century
1
1999
244
0.080
Why?
Transcription Factors
1
2004
687
0.080
Why?
Muramidase
1
1978
37
0.080
Why?
Mice
5
1982
6111
0.080
Why?
Interleukin-4
1
1998
163
0.070
Why?
Cell Adhesion
2
1988
261
0.070
Why?
Interleukin-2
1
1998
198
0.070
Why?
Immunocompromised Host
1
1998
83
0.070
Why?
Antilymphocyte Serum
2
1989
25
0.070
Why?
Logistic Models
2
2009
611
0.070
Why?
Data Collection
1
1998
215
0.070
Why?
Delivery of Health Care
1
1999
146
0.070
Why?
Flow Cytometry
3
1987
603
0.070
Why?
Membrane Proteins
1
2001
540
0.070
Why?
Prevalence
2
2006
562
0.070
Why?
Sex Distribution
2
2006
160
0.070
Why?
Thrombin
2
2007
132
0.070
Why?
Family
2
1987
201
0.070
Why?
Quality of Life
1
2000
502
0.070
Why?
Hospital Charges
1
1996
14
0.070
Why?
Binding, Competitive
3
1983
198
0.070
Why?
Reactive Oxygen Species
2
2008
301
0.070
Why?
Cell Line, Tumor
2
2008
575
0.070
Why?
Recombinant Proteins
1
1998
723
0.070
Why?
RNA, Messenger
3
2004
1863
0.070
Why?
Administration, Oral
2
1982
308
0.070
Why?
Bone Marrow Cells
2
2004
221
0.060
Why?
Thiazolidinediones
2
2004
73
0.060
Why?
Graft Enhancement, Immunologic
2
1990
3
0.060
Why?
Combined Modality Therapy
2
1988
486
0.060
Why?
Up-Regulation
2
2003
363
0.060
Why?
Sex Factors
2
1982
597
0.060
Why?
Linear Models
1
1996
237
0.060
Why?
Remission Induction
1
1995
161
0.060
Why?
Mice, Inbred C57BL
2
2009
1675
0.060
Why?
Confounding Factors (Epidemiology)
1
1994
61
0.060
Why?
RNA, Neoplasm
1
1974
67
0.060
Why?
Anemia, Aplastic
2
1983
25
0.060
Why?
Multivariate Analysis
1
1995
541
0.060
Why?
Binding Sites
1
1996
690
0.060
Why?
Analysis of Variance
1
1996
736
0.060
Why?
Molecular Weight
1
1993
353
0.050
Why?
Immunoblotting
1
1993
211
0.050
Why?
Gastrointestinal Hemorrhage
2
1983
84
0.050
Why?
Reoperation
1
1993
183
0.050
Why?
Cell Survival
1
1994
551
0.050
Why?
Hematinics
1
2012
8
0.050
Why?
Phenotype
2
1987
763
0.050
Why?
Complement C2
1
1992
8
0.050
Why?
Immobilization
1
2012
28
0.050
Why?
Skilled Nursing Facilities
1
2012
20
0.050
Why?
Kidney Failure, Chronic
2
1983
122
0.050
Why?
Complement C4
1
1992
22
0.050
Why?
Ambulatory Care Facilities
1
2012
33
0.050
Why?
Hydrops Fetalis
1
1991
16
0.050
Why?
Fibroblasts
2
2003
534
0.050
Why?
Cross-Over Studies
1
2012
128
0.050
Why?
Antibody Formation
1
1992
179
0.050
Why?
Home Care Services
1
2012
43
0.050
Why?
Albumins
1
1992
54
0.050
Why?
Office Visits
1
2012
88
0.050
Why?
Megakaryocyte Progenitor Cells
1
2011
3
0.050
Why?
Ultraviolet Rays
1
1992
199
0.050
Why?
Kinetics
2
1983
1391
0.050
Why?
Cell Differentiation
2
2003
1093
0.050
Why?
Administration, Rectal
1
2010
5
0.050
Why?
Suppositories
1
2010
5
0.050
Why?
Immunosuppression
1
1990
64
0.050
Why?
Medicare
1
2012
129
0.050
Why?
Platelet Function Tests
1
2010
15
0.050
Why?
Melanoma
1
1992
134
0.050
Why?
Crohn Disease
1
1990
88
0.040
Why?
Comorbidity
1
2012
380
0.040
Why?
Bleeding Time
1
1990
10
0.040
Why?
Leukemia, Megakaryoblastic, Acute
1
2009
10
0.040
Why?
Bone Neoplasms
1
1992
207
0.040
Why?
Age Distribution
1
2010
221
0.040
Why?
Cell Shape
1
2009
21
0.040
Why?
Sulfones
1
2009
25
0.040
Why?
Nitriles
1
2009
40
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2011
92
0.040
Why?
Deamino Arginine Vasopressin
1
1990
23
0.040
Why?
NF-kappa B p50 Subunit
1
2009
34
0.040
Why?
Michigan
1
2009
19
0.040
Why?
Emergency Service, Hospital
1
2012
213
0.040
Why?
Cyclic AMP-Dependent Protein Kinases
1
2010
126
0.040
Why?
Clostridium difficile
1
2009
13
0.040
Why?
Enterocolitis, Pseudomembranous
1
2009
19
0.040
Why?
Integrin alpha2beta1
1
2009
8
0.040
Why?
Immune Sera
1
1989
73
0.040
Why?
Inflammation Mediators
1
2010
113
0.040
Why?
Pregnancy Complications
1
1991
198
0.040
Why?
Adsorption
1
1989
87
0.040
Why?
Immunity, Cellular
1
1990
132
0.040
Why?
Case-Control Studies
1
2011
617
0.040
Why?
Transcription Factor RelA
1
2009
76
0.040
Why?
Blood Cells
1
2009
18
0.040
Why?
Hemophilia A
1
1989
30
0.040
Why?
Chromatography, Ion Exchange
1
1989
61
0.040
Why?
Dose-Response Relationship, Immunologic
1
1988
60
0.040
Why?
von Willebrand Diseases
1
1989
22
0.040
Why?
Mass Spectrometry
1
2009
115
0.040
Why?
Statistics as Topic
1
2009
185
0.040
Why?
Hospitals
1
2009
65
0.040
Why?
Chromatography, High Pressure Liquid
1
2009
208
0.040
Why?
HIV Seropositivity
1
1988
34
0.040
Why?
European Continental Ancestry Group
1
2010
234
0.040
Why?
Epidemiologic Research Design
1
2008
3
0.040
Why?
Species Specificity
1
2009
341
0.040
Why?
Multicenter Studies as Topic
1
1988
129
0.040
Why?
African Americans
1
2010
219
0.040
Why?
Acetylcysteine
1
2008
78
0.040
Why?
Retinoid X Receptor beta
1
2008
5
0.040
Why?
HLA-B Antigens
2
1984
14
0.040
Why?
Retinoid X Receptor alpha
1
2008
7
0.040
Why?
Thiazolidines
1
2008
11
0.040
Why?
Bicyclo Compounds, Heterocyclic
1
2008
14
0.040
Why?
Skin Diseases
1
2009
120
0.040
Why?
Cause of Death
1
2009
162
0.040
Why?
Intraoperative Period
1
1987
46
0.040
Why?
Radiation Injuries, Experimental
1
2008
90
0.040
Why?
Respiratory Tract Infections
1
2009
159
0.040
Why?
Anemia, Refractory
1
1987
7
0.040
Why?
Binding Sites, Antibody
2
1983
32
0.040
Why?
Parental Notification
1
1987
2
0.040
Why?
Pregnant Women
1
1987
4
0.040
Why?
Minors
1
1987
5
0.040
Why?
State Government
1
1987
14
0.040
Why?
Protein Isoforms
1
2008
114
0.040
Why?
Contraception
1
1987
22
0.040
Why?
Dimerization
1
2008
157
0.040
Why?
Confidence Intervals
1
2007
165
0.040
Why?
Liability, Legal
1
1987
24
0.040
Why?
Blotting, Western
1
2009
645
0.040
Why?
Sexually Transmitted Diseases
1
1987
31
0.040
Why?
Kidney Diseases
1
1989
170
0.040
Why?
Disseminated Intravascular Coagulation
1
1986
15
0.040
Why?
Regression Analysis
1
1988
527
0.040
Why?
Specimen Handling
1
2007
71
0.040
Why?
Child Abuse
1
1987
43
0.040
Why?
Blood Coagulation Disorders
1
1986
37
0.030
Why?
Glutathione
1
2008
230
0.030
Why?
Antioxidants
1
2008
205
0.030
Why?
Reference Values
1
2007
439
0.030
Why?
Collagen
1
2008
290
0.030
Why?
Cross-Linking Reagents
1
2006
78
0.030
Why?
Monocytes
1
2008
308
0.030
Why?
Peptide Fragments
1
2008
282
0.030
Why?
Mice, Knockout
1
2009
895
0.030
Why?
Risk Assessment
1
2010
884
0.030
Why?
Cell Proliferation
1
2009
515
0.030
Why?
Parents
1
1987
165
0.030
Why?
Drug Delivery Systems
1
2006
59
0.030
Why?
Physicians
1
1987
157
0.030
Why?
Pancytopenia
1
2005
13
0.030
Why?
Transplantation Chimera
1
2005
26
0.030
Why?
Leukocyte Count
2
1981
161
0.030
Why?
Algorithms
1
2009
541
0.030
Why?
Protein Binding
1
2008
827
0.030
Why?
Whole-Body Irradiation
1
2005
83
0.030
Why?
Young Adult
1
2009
1059
0.030
Why?
HLA-A2 Antigen
1
1984
9
0.030
Why?
Maternal-Fetal Exchange
1
1985
141
0.030
Why?
Cell Membrane
1
2006
482
0.030
Why?
MNSs Blood-Group System
1
1983
5
0.030
Why?
Myometrium
1
2003
21
0.030
Why?
Cryoglobulins
1
1983
22
0.030
Why?
Follow-Up Studies
1
1988
1855
0.030
Why?
Chromium Radioisotopes
1
1983
6
0.030
Why?
Sodium Pertechnetate Tc 99m
1
1983
10
0.030
Why?
Immunosuppressive Agents
1
2005
200
0.030
Why?
Orbit
1
2003
63
0.030
Why?
Purpura, Thrombotic Thrombocytopenic
1
1983
11
0.030
Why?
Hypoglycemic Agents
1
2004
108
0.030
Why?
Hypotension, Orthostatic
1
1982
11
0.030
Why?
Cost Control
1
1983
37
0.030
Why?
Lymphocytes
1
1984
291
0.030
Why?
DNA
1
2008
845
0.030
Why?
Endothelium, Vascular
1
2006
406
0.030
Why?
Actins
1
2003
192
0.030
Why?
Centrifugation
2
1978
46
0.030
Why?
Red Cross
1
1982
1
0.030
Why?
Connecticut
1
1982
10
0.030
Why?
Glycerol
1
1982
53
0.020
Why?
Adenosine Triphosphate
1
2004
404
0.020
Why?
Injections, Intravenous
1
1982
131
0.020
Why?
Interferon-gamma
1
2003
348
0.020
Why?
Evaluation Studies as Topic
2
1987
245
0.020
Why?
Prednisone
1
1982
165
0.020
Why?
Fluid Therapy
1
1981
29
0.020
Why?
Dexamethasone
1
1982
181
0.020
Why?
Gene Expression
1
2004
751
0.020
Why?
Heart Injuries
1
1960
15
0.020
Why?
Transforming Growth Factor beta
1
2003
412
0.020
Why?
Lung
1
2006
1159
0.020
Why?
DNA-Binding Proteins
1
2004
685
0.020
Why?
Military Medicine
1
1978
19
0.020
Why?
Intestinal Obstruction
1
1958
36
0.020
Why?
Resuscitation
1
1978
48
0.020
Why?
Dose-Response Relationship, Drug
1
1982
1117
0.020
Why?
Hospitals, Teaching
1
1978
81
0.020
Why?
Filtration
1
1978
29
0.020
Why?
L-Lactate Dehydrogenase
1
1978
87
0.020
Why?
Hemoglobins
1
1978
95
0.020
Why?
Transplantation Immunology
1
1996
18
0.020
Why?
Isoantigens
1
1996
24
0.020
Why?
Adoptive Transfer
1
1996
27
0.020
Why?
Lymphocyte Subsets
1
1996
27
0.020
Why?
Mice, Inbred Strains
1
1996
245
0.020
Why?
Forecasting
1
1996
177
0.020
Why?
Histocompatibility
1
1994
13
0.020
Why?
Neoplasm Metastasis
1
1996
228
0.020
Why?
Transplantation, Autologous
1
1994
144
0.020
Why?
Poly I-C
1
1974
10
0.010
Why?
Dactinomycin
1
1974
55
0.010
Why?
Ribonucleases
1
1974
70
0.010
Why?
Carmustine
1
1992
37
0.010
Why?
Dacarbazine
1
1992
21
0.010
Why?
Pregnancy Trimester, Third
1
1991
51
0.010
Why?
Antibodies, Anti-Idiotypic
1
1991
51
0.010
Why?
Karyotyping
1
1991
109
0.010
Why?
Prenatal Diagnosis
1
1991
53
0.010
Why?
Cisplatin
1
1992
95
0.010
Why?
Tamoxifen
1
1992
81
0.010
Why?
Lymphatic Metastasis
1
1992
142
0.010
Why?
Cesarean Section
1
1991
73
0.010
Why?
Disease Susceptibility
1
1990
79
0.010
Why?
Burns
1
1990
63
0.010
Why?
Dogs
1
1990
468
0.010
Why?
HLA-A Antigens
1
1987
7
0.010
Why?
Immunoassay
1
1987
40
0.010
Why?
Hydrogen-Ion Concentration
1
1987
566
0.010
Why?
Predictive Value of Tests
1
1987
606
0.010
Why?
Vincristine
1
1983
62
0.010
Why?
Splenectomy
1
1983
35
0.010
Why?
Steroids
1
1983
54
0.010
Why?
Ultrafiltration
1
1982
8
0.010
Why?
Freezing
1
1982
30
0.010
Why?
Drug Packaging
1
1982
8
0.010
Why?
Rats
1
1990
4289
0.010
Why?
Paresthesia
1
1981
18
0.010
Why?
Candidiasis
1
1982
41
0.010
Why?
Cellulitis
1
1979
11
0.010
Why?
Rectal Diseases
1
1979
17
0.010
Why?
Abscess
1
1979
51
0.010
Why?
Pneumonia
1
1979
196
0.000
Why?

Visualizations


Blumberg's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department